A Comparison of Community and Occupationally Provided Antihypertensive Care

Autor: Logan, Alexander G., Milne, Barbara J., Achber, Christine, Campbell, Wendy A., Haynes, R. Brian
Zdroj: Journal of Occupational Medicine; November 1982, Vol. 24 Issue: 11 p901-906, 6p
Abstrakt: The process and cost of a work-site (WS) hypertension treatment program and their relationship to outcome were compared in a randomized controlled trial with care delivered in the community (regular care [RC]). At the year-end assessment, significantly more WS than RC patients were on antihypertensive medication (73.3 v 59.6, p < .001), were on more than one type of antihypertensive medication (40.3 v 13.3, p < .005) and were visiting the therapist more frequently (8.6 ± 0.2 v 5.7 ± 0.3 visits per annum, p < .001). Furthermore, WS patients were significantly more likely to remain in care (90.4 v 75.4 p < .001) and more satisfied with the care received (p < .001) than RC patients. Medication compliance was not significantly different in the two groups. The percent of WS patients at or below goal blood pressure (BP) was significantly greater compared with that for RC patients (60.3 v 32.5, p < .001). The total cost of the WS program was 242.86 per patient compared with 211.34 per patient for RC treatment. Since the mean reduction in diastolic BP was significantly greater in the WS group (12.1 ± 0.6 v 6.5 ± 0.6 mm Hg, p < .001), WS treatment was highly cost-effective. The incremental cost of lowering diastolic BP in the WS group was 5.63 per mm Hg and was less than the base cost-effectiveness ratio of 32.51 per mm Hg for regular care, indicating that the WS program was substantially more cost-effective. Until there is significant improvement in performance of primary care physicians in the treatment of hypertension, special WS treatment programs will continue to be an attractive alternative to achieve good BP control in the community.
Databáze: Supplemental Index